Development of clinical decision tools for management of diarrhea of children in high and low resource settings

开发资源丰富和匮乏环境下儿童腹泻管理的临床决策工具

基本信息

  • 批准号:
    10649542
  • 负责人:
  • 金额:
    $ 45.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-08 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

Abstract Diarrheal diseases are the among the leading cause of death in children worldwide, most of which occur in low-income countries. In high-income countries, pediatric diarrhea remains a major utilization of healthcare resources. The cornerstone for management of diarrhea is rehydration, though antimicrobials are beneficial in some instances. Unfortunately, given that treatment is frequently empiric, based mostly on clinical suspicion for bacterial causes, antimicrobials are overused in management of diarrheal illness worldwide. In high-income countries, diagnostic testing is oftentimes overutilized. Thus, there is a need for clinical decision support tools for antimicrobial and diagnostic stewardship in many settings. Current clinical prediction tools are based mostly on patient-intrinsic properties such as the clinical exam and symptom history specific for that patient. We have preliminary data suggesting that the integration of patient-extrinsic data, including climate and seasonality parameters, and population-level pre-test probabilities (from prior patients and prior years’ prevalence), can improve the performance of a clinical prediction model. We also have preliminary data showing the potential for an electronic clinical decision-support tool (eCDST) that estimates diarrheal etiology to decrease antibiotic prescription rates. Our overarching goal is to: 1) improve diarrhea clinical prediction through integration of patient-extrinsic data sources, and 2) explore the potential feasibility and utility of an eCDST, such as a smartphone application or an electronic health record tool. In Aim 1, we will use data from several prospective clinical studies of pediatric diarrhea to build improved clinical prediction models that includes patient-extrinsic data sources. In Aim 2, we will determine the potential feasibility, utility, and economic impact of an eCDST for antibiotic and diagnostic stewardship by examining clinican and caregiver perspectives through in-depth interviews and focus groups. We will also perform an economic evaluation of eCDST in a US setting. Completion of the Aims will result in an optimized clinical prediction model using big data and lay the groundwork needed to inform the design of implementation studies of eCDSTs for management of pediatric diarrhea.
摘要 腹泻病是全世界儿童死亡的主要原因之一,其中大多数发生在 低收入国家。在高收入国家,儿科腹泻仍然是医疗保健的主要用途 资源腹泻管理的基础是补液,尽管抗菌药物在治疗腹泻中是有益的。 一些实例。不幸的是,由于治疗通常是经验性的,主要是基于临床怀疑, 由于细菌原因,在世界范围内,抗菌药物在治疗疟疾疾病中被过度使用。在高收入 在一些国家,诊断检测常常被过度使用。因此,需要临床决策支持工具 在许多环境中进行抗菌和诊断管理。目前的临床预测工具主要基于 患者固有属性,例如该患者的临床检查和症状史。我们有 初步数据表明,患者外部数据的整合,包括气候和季节性 参数和人群水平的预检验概率(来自既往患者和既往患病率),可以 改善临床预测模型的性能。我们也有初步的数据显示, 一种电子临床决策支持工具(eCDST),用于估计腹泻病因,以减少抗生素 处方药费率。我们的总体目标是:1)通过整合以下指标来改善腹泻临床预测: 患者外部数据源,以及2)探索eCDST的潜在可行性和实用性,例如 智能手机应用程序或电子健康记录工具。在目标1中,我们将使用来自几个前瞻性研究的数据, 儿科腹泻的临床研究,以建立改进的临床预测模型, 数据源在目标2中,我们将确定eCDST的潜在可行性、实用性和经济影响, 通过深入研究临床医生和护理人员的观点, 访谈和焦点小组。我们还将在美国环境中对eCDST进行经济评估。 目标的完成将导致使用大数据的优化临床预测模型,并奠定 为设计用于儿科疾病管理的eCDST实施研究提供信息所需的基础工作 腹泻

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Drivers of inappropriate use of antimicrobials in South Asia: A systematic review of qualitative literature.
南亚不当使用抗菌药物的驱动因素:定性文献的系统回顾。
  • DOI:
    10.1101/2023.09.28.23296313
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Murray,JenniferL;Leung,DanielT;Hanson,OliviaR;Ahmed,ShariaM;Pavia,AndrewT;Khan,AshrafulI;Szymczak,JuliaE;Vaughn,ValerieM;Patel,PayalK;Biswas,Debashish;Watt,MelissaH
  • 通讯作者:
    Watt,MelissaH
Derivation and External Validation of a Clinical Prediction Model for Viral Diarrhea Etiology in Bangladesh.
Qualitative Assessment of a Smartphone-Based Mobile Health Tool to Guide Diarrhea Management in Bangladesh.
Assessment of Model Estimated and Directly Observed Weather Data for Etiological Prediction of Diarrhea.
评估用于腹泻病因预测的模型估计和直接观测的天气数据。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Ted Leung其他文献

Daniel Ted Leung的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Ted Leung', 18)}}的其他基金

Mentoring patient-oriented researchers in pediatric diarrhea
指导以患者为中心的小儿腹泻研究人员
  • 批准号:
    10591728
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
Development of clinical decision tools for management of diarrhea of children in high and low resource settings
开发资源丰富和匮乏环境下儿童腹泻管理的临床决策工具
  • 批准号:
    10522523
  • 财政年份:
    2018
  • 资助金额:
    $ 45.28万
  • 项目类别:
Estimating Cholera Burden with Cross-sectional Immunologic Data
用横截面免疫学数据估计霍乱负担
  • 批准号:
    10132972
  • 财政年份:
    2018
  • 资助金额:
    $ 45.28万
  • 项目类别:
Estimating Cholera Burden with Cross-sectional Immunologic Data
用横截面免疫学数据估计霍乱负担
  • 批准号:
    9912094
  • 财政年份:
    2018
  • 资助金额:
    $ 45.28万
  • 项目类别:
Development of clinical decision tools for management of diarrhea of children in high and low resource settings
开发资源丰富和匮乏环境下儿童腹泻管理的临床决策工具
  • 批准号:
    9912093
  • 财政年份:
    2018
  • 资助金额:
    $ 45.28万
  • 项目类别:
Estimating Cholera Burden with Cross-sectional Immunologic Data
用横截面免疫学数据估计霍乱负担
  • 批准号:
    10388296
  • 财政年份:
    2018
  • 资助金额:
    $ 45.28万
  • 项目类别:
Mucosal associated invariant T (MAIT) cells in Vibrio cholerae infection and vaccination
霍乱弧菌感染和疫苗接种中的粘膜相关不变 T (MAIT) 细胞
  • 批准号:
    10153667
  • 财政年份:
    2017
  • 资助金额:
    $ 45.28万
  • 项目类别:
Mucosal associated invariant T (MAIT) cells in Vibrio cholerae infection and vaccination
霍乱弧菌感染和疫苗接种中的粘膜相关不变 T (MAIT) 细胞
  • 批准号:
    9926810
  • 财政年份:
    2017
  • 资助金额:
    $ 45.28万
  • 项目类别:
Mucosal associated invariant T (MAIT) cells in Vibrio cholerae infection and vaccination
霍乱弧菌感染和疫苗接种中的粘膜相关不变 T (MAIT) 细胞
  • 批准号:
    9398501
  • 财政年份:
    2017
  • 资助金额:
    $ 45.28万
  • 项目类别:
Immune responses to Vibrio cholerae in children
儿童对霍乱弧菌的免疫反应
  • 批准号:
    8517006
  • 财政年份:
    2012
  • 资助金额:
    $ 45.28万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 45.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了